Cervical cancer shot gains acceptance

ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said. The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co. 's Gardasil vaccine, the Centers for Disease Control and Prevention said. Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes. Human... [read full story]